Pop Pop | Where to get the best fireworks in America.
How to Make Google+ Look Like Facebook+ [Google+]
Not sure why'd you want to, but if you're so hooked on Facebook you can't imagine getting your social networking on anywhere else—yet can't quite turn down a Google+ invite—there's a way to satisfy your eyes, at least. More »
Le_rn Ru__ian _ith C_ossw_rd P_zzl_s – Honey, What’s a 32-Letter Phrase for Language Learning App? [Apps]
The next time Russia invades the Mid West, Patrick Swayze and Charlie Sheen won't be there to save us so it's a damn good idea to brush up on your Cyrillic now and avoid the rush. More »
Google+ Gives the Gift of Unlimited Picasa Storage [Blip]
Picasa is limited to 1GB of storage (unless you pay up for more Google bytes) but now there's a free workaround. You can upload unlimited photos (smaller than 2048x2048) and videos (under 15 minutes) Google+ and it doesn't touch your storage limit. [ReadWriteWeb] More »
The Best Apps of the Week [Apps]
In this week's app roundup: Google+, unveiled; GPS, painted with direction; North Korea, photographed; iPhones, playing dead; Instagram, challenged by Google; background checks, forever creepy; fourways, on Fring; and much, much more. More »
Innovative Impfstoffe durch Nanotechnologie
Forscherkonsortium will neuartige Impfung gegen Hepatitis C entwickeln.
Siltronic AG Joins imec’s GaN-on-Si Research Program to Develop Technology for Next-Gen Power Semiconductors and LEDs
Siltronic AG and the Belgian nano-electronics research institute imec have concluded an agreement to collaborate on the development of silicon wafers with a gallium nitride layer as partner of imec's GaN-on-Si industrial affiliation program (IIAP). The endeavor aims to enable production of solid-state lighting (e.g. LEDs) and power semiconductors of the next generation on 200 mm silicon wafers.
Patent analysis and product survey on use of nanomaterials in lithium-ion batteries
The efforts undertaken in developing renewable energy sources to reduce our dependence on fossil fuels include major research and investment in advanced electricity storage technologies. Among the various existing technologies, lithium batteries are considered as the most competitive power source because of their high energy density, superior power capability, design flexibility and longer lifespan. This article provides an overview of the current patent landscape of rechargeable Li-ion battery, with a focus on the recent developments on nanomaterials and nanotechnologies used for anode, cathode, and electrolyte materials, and the impact of nanomaterials on the performance of rechargeable lithium batteries. Effort has also been taken to identify key players, emerging trends and applications in this area.
Embracing superficial imperfections
Numerical simulations reveal that deliberately engineering defects into ultrathin oxide films enhances catalytic water-splitting reactions.
Nanowires offer opportunities for improved LEDs
Researchers from the FOM Institute AMOLF, together with colleagues from Philips Research, Eindhoven University of Technology and Delft University of Technology, have made special nanostructures that could be used as light-emitting diodes (LEDs). These nanostructures can be used to control the direction of the emission.
Shedding light on Kondo correlations
Scientists from ETH Zurich, LMU Munich, Princeton and Yale Universities have used resonant laser absorption to examine how a quantum dot with Kondo correlations responds to a quantum quench, i.e. to an abrupt change in the interactions that give rise to Kondo correlations in the first place.
New technique advances bioprinting of cells
By extending his pioneering acoustical work that applied sound waves to generate droplets from fluids, Dr. Utkan Demirci and his team at Harvard Medical School's (Brigham and Women's Hospital) Bio-Acoustic Mems in Medicine Laboratory report encouraging preliminary results at an early and crucial point in a stem cell's career known as embroid body formation.
Printed nanotechnology solar cells could dramatically reduce costs
Australian researchers have invented nanotech solar cells that are thin, flexible and use one hundredth the materials of conventional solar cells.
Faster 3-D nanoimaging a possibility with full color synchrotron light
Researchers can now see objects more precisely and faster at the nanoscale due to utilising the full colour spectrum of synchrotron light, opening the way for faster 3D nanoimaging.
Magnetic memory and logic could achieve ultimate energy efficiency
Magnetic microprocessors could use million times less energy than today's silicon chips.
Guitar hero? Special thin-film on guitar converts string tension into digital control signals
Guitar virtuosos have to master all kinds of playing techniques. But how can the intricate process of playing the instrument be captured digitally? A special thin film on the tailpiece has the answer. Functioning as a sensor, it converts the tension on the string into digital control signals.
Japanese-German Micro/Nano Business Forum meets in Tokyo
Like the years before, IVAM Microtechnology Network is organizing the Japanese-German Micro / Nano Business Forum within the "Micromachine/MEMS" in Tokyo, one of the most important exhibitions in the field of micro and nanotechnology in Japan.
Gay Men More Likely to Have Had Cancer
(HealthDay News) -- A new study finds that homosexual men are twice as likely as other males to have been diagnosed with and then survive a cancer, shining a light on the unique medical risks that gay people may face.
It's not the first time that researchers have noted differences in health risks linked to sexual orientation. Gay men, of course, are at higher risk of becoming infected with HIV, while lesbians may be more likely than heterosexual women to get breast cancer. Both gay men and lesbians have higher rates of tobacco use than the general population, and research has shown that lesbians drink more and are more prone to obesity than other women.
The new study adds to existing knowledge, but "there's a painful dearth of data about lesbian, gay, bisexual and transgender health in general," noted Liz Margolies, executive director of the National LGBT Cancer Network, who's familiar with the new research. Read more...
Joint Mender for Joint Care
Humorous pathology videos from University of Florida Department of Pathology
A loyal reader put me onto DRdoubleB over at YouTube, a pathology resident at the University of Florida who put together some high quality music videos with a pathology theme.
Check out "Dynamite Case" about the trials and tribulations of daily sign-out, grossing and trying to go to meetings, "I Got It" for nailing a sarcoma diagnosis & "I Like Path That Way" which has more attending input on the video. Pretty sure my attendings in residency would either not have supported these videos or appeared in them.
Looks like a fun department with a talented resident and supporting cast.
Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
Partnership forged to tackle tumor heterogeneity
Cambridge, MA and Munich, Germany – June 30, 2011 – Metamark Genetics, a privately held oncology molecular diagnostic company, and Definiens, the leading Health Image Intelligence™ company, today announced a development and commercialization partnership in which Metamark will combine its proprietary multiplex protein detection platform with image analysis technology developed jointly with Definiens to deliver innovative prognostic and predictive assays for early-stage cancers.
"Definiens is a clear world leader in quantitative digital pathology and in the analysis of biomarkers in tissue image data,” said Eric Devroe, Ph.D, Vice President of Business & Strategy Development for Metamark. “We see great synergy in combining Definiens’ technology and expertise with Metamark’s unique understanding of tumor heterogeneity and insight into the molecular drivers regulating tumor formation and aggression. We believe that this partnership will enable us to co-develop and implement unique and important image analysis tools."
Metamark’s quantitative diagnostic approach can identify and account for small regions of molecularly aggressive cancer cells within an otherwise indolent tumor. The company is developing a portfolio of prognostic and predictive assays with the ability to address the "heterogeneous" nature of tumors not only between one patient and the next, but also within an individual patient’s tumor.
Definiens has made ground-breaking achievements in the field of biomarker development based on its highly robust and scalable image analysis framework that enables scientists and clinicians to rapidly extract comprehensive biomarker and morphology expression profiles and to identify a relevant subset of descriptors by correlating them against patient outcomes.
"Definiens is pleased to partner with Metamark Genetics, and to incorporate our image and data analysis software technology into Metamark’s pioneering Oncology diagnostic offerings," said Thomas Colarusso, Vice President of Sales & Operations for Definiens Inc. "The capability to provide detailed readouts from tissue analysis is opening up new gateways for developing diagnostic assays as we enter the age of personalized medicine. We believe the Definiens Developer XD and Tissue Studio software will enable Metamark to classify tumor heterogeneity of multiplexed tissue stains and derive prognostic and predictive assays."
About Metamark Genetics, Inc.
Metamark is a privately held oncology company focused on the development of function-based prognostic assays for early staged cancers. The MetamarkDx™ Prognostic Assays under development are based on Metamark’s proprietary Prognosis Determinants™, genes discovered through leading edge cancer research and demonstrated to play a causal role in promoting tumor progression and spread. For further information, please visit the company’s website at http://www.metamarkgenetics.com.
About Definiens
Definiens is a leading Health Image Intelligence™ company that develops software solutions for biomedical image analysis, data mining and clinical decision support. The company’s software analyzes images from cell-based assays, whole tissue slides and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics and therapy. By automating analysis workflows and generating new knowledge, Definiens provides pharmaceutical and biotechnology companies, research institutions, clinical service organizations and medical professionals with deeper insights, faster results and better decision support. Harnessing the power of image intelligence, Definiens supports personalized medicine and aims to significantly improve the quality of patients’ lives. Definiens is headquartered in Munich, Germany, and has offices throughout the United States. Further information is available at http://www.definiens.com.
